|
1
|
DeAngelis LM: Brain tumors. N Engl J Med.
344:114–123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Asklund T, Malmstrom A, Bergqvist M, Björ
O and Henriksson R: Brain tumors in Sweden: Data from a
population-based registry 1999–2012. Acta Oncol. 54:377–384. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Tonn JC, Brada M and
Pentheroudakis G: ESMO Guidelines Working Group: High-grade
malignant glioma: ESMO clinical practice guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 21:(Suppl 5). v190–v193. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mrugala MM, Adair J and Kiem HP:
Temozolomide: Expanding its role in brain cancer. Drugs Today
(Barc). 46:833–846. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hannigan GE, Leung-Hagesteijn C,
Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC and Dedhar
S: Regulation of cell adhesion and anchorage-dependent growth by a
new beta 1-integrin-linked protein kinase. Nature. 379:91–96. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dedhar S: Cell-substrate interactions and
signaling through ILK. Curr Opin Cell Biol. 12:250–256. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmitz M, Grignard G, Margue C, Dippel W,
Capesius C, Mossong J, Nathan M, Giacchi S, Scheiden R and Kieffer
N: Complete loss of PTEN expression as a possible early prognostic
marker for prostate cancer metastasis. Int J Cancer. 120:1284–1292.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gil D, Ciołczyk-Wierzbicka D,
Dulińska-Litewka J, Zwawa K, McCubrey JA and Laidler P: The
mechanism of contribution of integrin linked kinase (ILK) to
epithelial-mesenchymal transition (EMT). Adv Enzyme Regul.
51:195–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsui Y, Assi K, Ogawa O, Raven PA,
Dedhar S, Gleave ME, Salh B and So AI: The importance of
integrin-linked kinase in the regulation of bladder cancer
invasion. Int J Cancer. 130:521–531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Serrano I, McDonald PC, Lock FE and Dedhar
S: Role of the integrin-linked kinase (ILK)/Rictor complex in
TGFβ-1-induced epithelial-mesenchymal transition (EMT). Oncogene.
32:50–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen D, Zhang Y, Zhang X, Li J, Han B, Liu
S, Wang L, Ling Y, Mao S and Wang X: Overexpression of
integrin-linked kinase correlates with malignant phenotype in
non-small cell lung cancer and promotes lung cancer cell invasion
and migration via regulating epithelial-mesenchymal transition
(EMT)-related genes. Acta Histochem. 115:128–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Duxbury MS, Ito H, Benoit E, Waseem T,
Ashley SW and Whang EE: RNA interference demonstrates a novel role
for integrin-linked kinase as a determinant of pancreatic
adenocarcinoma cell gemcitabine chemoresistance. Clin Cancer Res.
11:3433–3438. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai DL, Makretsov N, Campos EI, Huang C,
Zhou Y, Huntsman D, Martinka M and Li G: Increased expression of
integrin-linked kinase is correlated with melanoma progression and
poor patient survival. Clin Cancer Res. 9:4409–4414.
2003.PubMed/NCBI
|
|
15
|
Sawai H, Okada Y, Funahashi H, Matsuo Y,
Takahashi H, Takeyama H and Manabe T: Integrin-linked kinase
activity is associated with interleukin-1 alpha-induced progressive
behavior of pancreatic cancer and poor patient survival. Oncogene.
25:3237–3246. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Zhang H, Wu J, Guan H, Yuan J, Huang
Z and Li M: Prognostic significance of integrin-linked kinase1
overexpression in astrocytoma. Int J Cancer. 126:1436–1444.
2010.PubMed/NCBI
|
|
17
|
Yu J, Shi R, Zhang D, Wang E and Qiu X:
Expression of integrin-linked kinase in lung squamous cell
carcinoma and adenocarcinoma: Correlation with E-cadherin
expression, tumor microvessel density and clinical outcome.
Virchows Arch. 458:99–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao D, Tang XF, Yang K, Liu JY and Ma XR:
Over-expression of integrin-linked kinase correlates with aberrant
expression of Snail, E-cadherin and N-cadherin in oral squamous
cell carcinoma: Implications in tumor progression and metastasis.
Clin Exp Metastasis. 29:957–969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhuang X, Lv M, Zhong Z, Zhang L, Jiang R
and Chen J: Interplay between intergrin-linked kinase and
ribonuclease inhibitor affects growth and metastasis of bladder
cancer through signaling ILK pathways. J Exp Clin Cancer Res.
35:1302016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hannigan G, Troussard AA and Dedhar S:
Integrin-linked kinase: A cancer therapeutic target unique among
its ILK. Nat Rev Cancer. 5:51–63. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Persad S and Dedhar S: The role of
integrin-linked kinase (ILK) in cancer progression. Cancer
Metastasis Rev. 22:375–384. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McDonald PC, Fielding AB and Dedhar S:
Integrin-linked kinase-essential roles in physiology and cancer
biology. J Cell Sci. 121:3121–3132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee SL, Chou CC, Chuang HC, Hsu EC, Chiu
PC, Kulp SK, Byrd JC and Chen CS: Functional role of mTORC2 versus
integrin-linked kinase in mediating Ser473-Akt phosphorylation in
PTEN-negative prostate and breast cancer cell lines. PLoS One.
8:e671492013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li R, Liu B, Yin H, Sun W, Yin J and Su Q:
Overexpression of integrin-linked kinase (ILK) is associated with
tumor progression and an unfavorable prognosis in patients with
colorectal cancer. J Mol Histol. 44:183–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Monferran S, Skuli N, Delmas C, Favre G,
Bonnet J, Cohen-Jonathan-Moyal E and Toulas C: Alphavbeta3 and
alphavbeta5 integrins control glioma cell response to ionising
radiation through ILK and RhoB. Int J Cancer. 123:357–364. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lanvin O, Monferran S, Delmas C, Couderc
B, Toulas C and Cohen-Jonathan-Moyal E: Radiation-induced mitotic
cell death and glioblastoma radioresistance: A new regulating
pathway controlled by integrin-linked kinase, hypoxia-inducible
factor 1 alpha and survivin in U87 cells. Eur J Cancer.
49:2884–2891. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hotchkiss RS, Strasser A, McDunn JE and
Swanson PE: Cell death. N Engl J Med. 361:1570–1583. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang T and Saghatelian A: Emerging roles
of lipids in BCL-2 family-regulated apoptosis. Biochim Biophys
Acta. 1831:1542–1554. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kouri FM, Jensen SA and Stegh AH: The role
of Bcl-2 family proteins in therapy responses of malignant
astrocytic gliomas: Bcl2L12 and beyond. ScientificWorldJournal.
2012:8389162012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song W, Jiang R and Zhao CM: Role of
integrin-linked kinase in multi-drug resistance of human gastric
carcinoma SGC7901/DDP cells. Asian Pac J Cancer Prev. 13:5619–5625.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mazumder S, Plesca D and Almasan A:
Caspase-3 activation is a critical determinant of genotoxic
stress-induced apoptosis. Methods Mol Biol. 414:13–21.
2008.PubMed/NCBI
|
